These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


557 related items for PubMed ID: 9816329

  • 1. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U, Benhar I, Webber KO, Pastan I, Brinkmann U.
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [Abstract] [Full Text] [Related]

  • 2. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
    Bera TK, Pastan I.
    Bioconjug Chem; 1998 Sep; 9(6):736-43. PubMed ID: 9815167
    [Abstract] [Full Text] [Related]

  • 3. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM, Geleick D, Rubira M, Clarke K, Nice EC, Smyth FE, Stockert E, Richards EC, Carr FJ, Harris WJ, Armour KL, Rood J, Kypridis A, Kronina V, Murphy R, Lee FT, Liu Z, Kitamura K, Ritter G, Laughton K, Hoffman E, Burgess AW, Old LJ.
    Cancer Res; 2000 Jun 15; 60(12):3254-61. PubMed ID: 10866319
    [Abstract] [Full Text] [Related]

  • 4. Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells.
    Mezzanzanica D, Canevari S, Mazzoni A, Figini M, Colnaghi MI, Waks T, Schindler DG, Eshhar Z.
    Cancer Gene Ther; 1998 Jun 15; 5(6):401-7. PubMed ID: 9917095
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE, Scallon BJ, Trinh H, Chernajovsky Y, Ghrayeb J, Feldmann M.
    Eur Cytokine Netw; 1998 Sep 15; 9(3):255-62. PubMed ID: 9831174
    [Abstract] [Full Text] [Related]

  • 7. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
    Wright P, Zheng C, Moyana T, Xiang J.
    Cancer Gene Ther; 1998 Sep 15; 5(6):371-9. PubMed ID: 9917092
    [Abstract] [Full Text] [Related]

  • 8. TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor.
    Wüest T, Gerlach E, Banerjee D, Gerspach J, Moosmayer D, Pfizenmaier K.
    Oncogene; 2002 Jun 20; 21(27):4257-65. PubMed ID: 12082613
    [Abstract] [Full Text] [Related]

  • 9. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W.
    Nature; 1993 Jan 21; 361(6409):266-9. PubMed ID: 8380906
    [Abstract] [Full Text] [Related]

  • 12. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation.
    Brinkmann U, Di Carlo A, Vasmatzis G, Kurochkina N, Beers R, Lee B, Pastan I.
    J Mol Biol; 1997 Apr 25; 268(1):107-17. PubMed ID: 9149145
    [Abstract] [Full Text] [Related]

  • 13. Selective formation of tumor necrosis factor-alpha (TNF) degradation products contributes to TNF mediated cytotoxicity.
    Fruehauf JP, Sinha BK.
    Oncol Res; 1992 Apr 25; 4(3):91-101. PubMed ID: 1319775
    [Abstract] [Full Text] [Related]

  • 14. Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro.
    Dettke M, Loibner H.
    Br J Cancer; 2000 Jan 25; 82(2):441-5. PubMed ID: 10646902
    [Abstract] [Full Text] [Related]

  • 15. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
    Liu M, Wang X, Yin C, Zhang Z, Lin Q, Zhen Y, Huang H.
    Biotechnol Appl Biochem; 2006 Mar 25; 43(Pt 3):137-45. PubMed ID: 16293104
    [Abstract] [Full Text] [Related]

  • 16. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB, Adams GP, Weiner LM, Marks JD.
    Cancer Res; 2000 Nov 15; 60(22):6434-40. PubMed ID: 11103810
    [Abstract] [Full Text] [Related]

  • 17. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.
    Melani C, Figini M, Nicosia D, Luison E, Ramakrishna V, Casorati G, Parmiani G, Eshhar Z, Canevari S, Colombo MP.
    Cancer Res; 1998 Sep 15; 58(18):4146-54. PubMed ID: 9751627
    [Abstract] [Full Text] [Related]

  • 18. Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coli.
    Kim S, Cheung LH, Zhang W, Rosenblum MG.
    Appl Microbiol Biotechnol; 2007 Nov 15; 77(1):99-106. PubMed ID: 17703297
    [Abstract] [Full Text] [Related]

  • 19. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK, Musyanovych A, Altvater M, Scheurich P, Pfizenmaier K, Landfester K, Kontermann RE.
    J Control Release; 2009 Jul 01; 137(1):69-77. PubMed ID: 19306900
    [Abstract] [Full Text] [Related]

  • 20. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia.
    Huang TH, Morrison SL.
    J Pharmacol Exp Ther; 2006 Mar 01; 316(3):983-91. PubMed ID: 16291729
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.